Combination treatments for overactive bladder refractory to first-line pharmacotherapy: do they meet expectations?

about

Combination treatments for overactive bladder refractory to first-line pharmacotherapy: do they meet expectations?

Item

http://www.wikidata.org/entity/Q48175777

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Combination treatments for ove ...... py: do they meet expectations?

@en

Combination treatments for ove ...... py: do they meet expectations?

@nl

type

Item

label

Combination treatments for ove ...... py: do they meet expectations?

@en

Combination treatments for ove ...... py: do they meet expectations?

@nl

prefLabel

Combination treatments for ove ...... py: do they meet expectations?

@en

Combination treatments for ove ...... py: do they meet expectations?

@nl

P1476

Combination treatments for ove ...... py: do they meet expectations?

@en

P2093

Apostolos Apostolidis

http://www.w3.org/2001/XMLSchema#string

P2860

β3-receptor agonists for overactive bladder--new frontier or more of the same?

Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison.

Can we create a valid treatment algorithm for patients with drug resistant overactive bladder (OAB) syndrome or detrusor overactivity (DO)? Results from a think tank (ICI-RS 2015).

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).

Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice.

Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony).

P304

459-460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/BJU.13988

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Apostolos Apostolidis

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29206354

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy